Determinants of Hypertension: A Cross-Sectional Analysis of Demographic and Physiological Predictors in a Referral Hospital in Iran
Novelty in Biomedicine,
Vol. 12 No. 4 (2024),
28 September 2024
,
Page 165-169
https://doi.org/10.22037/nbm.v12i4.45624
Abstract
Background: Hypertension is a leading risk factor for cardiovascular diseases, significantly contributing to global morbidity and mortality. Understanding the determinants of hypertension is crucial for effective prevention and management. This study investigates the relationships between demographic and physiological factors and hypertension status in a cohort of adults.
Materials and Methods: A cross-sectional study was conducted with 105 adult participants, comprising 47 hypertensive and 58 non-hypertensive individuals. Data on age, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglycerides, and fasting blood sugar (FBS) were collected. Statistical analyses included summary statistics, Pearson correlation coefficients, and logistic regression to identify significant predictors of hypertension.
Results: There were significant differences between hypertensive and non-hypertensive groups regarding SBP, DBP, and BMI. Hypertensive individuals had higher mean SBP (141.4 ± 10.5 mmHg) and DBP (86.4 ± 8.0 mmHg) compared to non-hypertensive individuals (118.1 ± 11.5 mmHg and 72.2 ± 6.8 mmHg, respectively; p < 0.001 for both). BMI was also significantly higher in the hypertensive group (36.8 ± 11.8 kg/m² vs. 32.6 ± 9.8 kg/m²; p < 0.001). Age and BMI positively correlated with both SBP and DBP, while HDL showed a significant negative correlation with DBP. Logistic regression analysis identified age (OR = 1.07, 95% CI: 1.05-1.09, p = 0.02), BMI (OR = 1.06, 95% CI: 1.01-1.15, p = 0.01), and LDL (OR = 1.04, 95% CI: 1.00-1.02, p = 0.04) as significant predictors of hypertension.
Conclusion: This study reinforces the significant roles of age, BMI, and LDL cholesterol in the risk of hypertension. These findings highlight the importance of targeting these modifiable risk factors through effective interventions to reduce the prevalence and impact of hypertension. Future research should explore the mechanisms linking these predictors to hypertension to develop comprehensive prevention and management strategies.
- Hypertension
- Blood pressure
- Body mass index
- Lipid profile
- Age
- Cardiovascular risk factors
- Predictors of hypertension
How to Cite
References
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nature Reviews Nephrology. 2020;16(4):223-37.
Brouwers S, Sudano I, Kokubo Y, Sulaica EM. Arterial hypertension. The Lancet. 2021;398(10296):249-61.
Ibrahim MM, Damasceno A. Hypertension in developing countries. The Lancet. 2012;380(9841):611-9.
Schroeder EB, Liao D, Chambless LE, Prineas RJ, Evans GW, Heiss G. Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study. Hypertension. 2003;42(6):1106-11.
Parati G. Blood pressure variability: its measurement and significance in hypertension. Journal of hypertension. 2005;23:S19-S25.
Messerli FH, Williams B, Ritz E. Essential hypertension. The Lancet. 2007;370(9587):591-603.
Alwardat N, Di Renzo L, de Miranda RC, Alwardat S, Salimei PS, De Lorenzo A. Association between hypertension and metabolic disorders among elderly patients in North Jordan. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;12(5):661-66.
Youk TM, Kang MJ, Song SO, Park E-C. Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics. BMJ Open Diabetes Research and Care. 2020;8(2):e001340.
Kim S, Choi S-Y, Lee H, Kim JJ, Park HE. Sex and age differences in the impact of metabolic syndrome and its components including a body shape index on arterial stiffness in the general population. Journal of Atherosclerosis and Thrombosis. 2022;29(12):1774-90.
Khodabakhshi A, Mahmoudabadi M, Vahid F. The role of serum 25 (OH) vitamin D level in the correlation between lipid profile, body mass index (BMI), and blood pressure. Clinical Nutrition ESPEN. 2022;48:421-6.
Gorial FI, Hameed JRA, Yassen NS. Relationship between serum lipid profile and hypertension. Journal of the Faculty of Medicine Baghdad. 2012;54(2):134-7.
Nayak P, Panda S, Thatoi PK, Rattan R, Mohapatra S, Mishra PK. Evaluation of lipid profile and apolipoproteins in essential hypertensive patients. Journal of clinical and diagnostic research: JCDR. 2016;10(10):BC01.
Ryomoto KI, Suzuki M, Kanazawa A, et al. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension. American journal of hypertension. 2000;13(6):617-24.
McEniery CM, Wilkinson IB, Avolio AP. Age, hypertension and arterial function. Clinical and Experimental Pharmacology and Physiology. 2007;34(7):665-71.
Borzecki AM, Glickman ME, Kader B, Berlowitz DR. The effect of age on hypertension control and management. American journal of hypertension. 2006;19(5):520-7.
Viera AJ, Neutze DM. Diagnosis of secondary hypertension: an age-based approach. American family physician. 2010;82(12):1471-8.
Daugherty SL, Masoudi FA, Ellis JL, et al. Age-dependent gender differences in hypertension management. Journal of hypertension. 2011;29(5):1005-11.
Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. Jama. 2005;294(4):466-72.
Wu J, Han X, Sun D, et al. Age-specific association of stage of hypertension at diagnosis with cardiovascular and all-cause mortality among elderly patients with hypertension: a cohort study. BMC Cardiovascular Disorders. 2023;23(1):270.
Datta BK, Haider MR, Tiwari A, Jahan M. The risk of hypertension among child brides and adolescent mothers at age 20 s, 30 s, and 40 s: Evidence from India. Journal of Human Hypertension. 2023;37(7):568-75.
Ali N, Ahmed S, Mahmood S, Trisha AD, Mahmud F. The prevalence and factors associated with obesity and hypertension in university academic staff: a cross-sectional study in Bangladesh. Scientific Reports. 2023;13(1):7309.
Ren H, Guo Y, Wang D, Kang X, Yuan G. Association of normal-weight central obesity with hypertension: a cross-sectional study from the China health and nutrition survey. BMC Cardiovascular Disorders. 2023;23(1):120.
Deng D, Chen C, Wang J, Luo S, Feng Y. Association between triglyceride glucose‐body mass index and hypertension in Chinese adults: A cross‐sectional study. The Journal of Clinical Hypertension. 2023;25(4):370-9.
Chen L, Zhang J, Zhou N, Weng J-Y, Bao Z-Y, Wu L-D. Association of different obesity patterns with hypertension in US male adults: a cross-sectional study. Scientific Reports. 2023;13(1):10551.
Kong G, Chin YH, Lim J, et al. A two‐decade population‐based study on the effect of hypertension in the general population with obesity in the United States. Obesity. 2023;31(3):832-40.
Wyszyńska J, Łuszczki E, Sobek G, Mazur A, Dereń K. Association and risk factors for hypertension and dyslipidemia in young adults from Poland. International Journal of Environmental Research and Public Health. 2023;20(2):982.
He D, Fan F, Jia J, et al. Lipid profiles and the risk of new-onset hypertension in a Chinese community-based cohort. Nutrition, Metabolism and Cardiovascular Diseases. 2021;31(3):911-20.
Kaneko H, Itoh H, Kiriyama H, et al. Lipid profile and subsequent cardiovascular disease among young adults aged< 50 years. The American Journal of Cardiology. 2021;142:59-65.
- Abstract Viewed: 44 times
- pdf Downloaded: 38 times